Tag: Hatch-Waxman

Why the First Generic Filer Gets 180-Day Exclusivity in the U.S. Drug Market

Why the First Generic Filer Gets 180-Day Exclusivity in the U.S. Drug Market
Posted by: Dorian Wellings in: Medications
15 Dec | 11:52 AM

The first generic drug company to file a patent challenge gets 180 days of exclusive sales rights. But this rule, meant to lower drug prices, is often manipulated-delaying competition and keeping patients from affordable medicines.

read more
Go!

recent posts

Hospital Formulary Economics: How Institutions Choose Generics to Cut Costs Without Compromising Care
Hospital Formulary Economics: How Institutions Choose Generics to Cut Costs Without Compromising Care

Hospitals choose generic drugs based on clinical safety, supply reliability, and real-world performance-not just price. Learn how Pharmacy and Therapeutics committees make these critical decisions under growing economic and regulatory pressure.

Published ON: 7 Feb
Formulation Differences and Side Effects: Tablets, Capsules, and Extended-Release Medications
Formulation Differences and Side Effects: Tablets, Capsules, and Extended-Release Medications

Learn how tablet, capsule, and extended-release formulations affect drug absorption and side effects. Discover why ER pills reduce nausea and dizziness - and when they might not be the best choice.

Published ON: 3 Feb
Generic Drug Price Trends: Year-by-Year Changes Explained
Generic Drug Price Trends: Year-by-Year Changes Explained

Explore how generic drug prices change yearly due to competition, regulations, and market dynamics. Learn why some generics spike in cost while others drop, and what this means for patients and healthcare.

Published ON: 6 Feb
ACE Inhibitors and ARBs in Pregnancy: Fetal Risks and Safe Alternatives
ACE Inhibitors and ARBs in Pregnancy: Fetal Risks and Safe Alternatives

ACE inhibitors and ARBs can harm a fetus during pregnancy. Learn about the risks, safe alternatives like labetalol and methyldopa, and steps to take if you're on these meds while pregnant.

Published ON: 4 Feb
How Lower Generic Drug Prices Boost Patient Adherence and Cut Healthcare Costs
How Lower Generic Drug Prices Boost Patient Adherence and Cut Healthcare Costs

Lower generic drug prices directly improve patient adherence, reduce hospitalizations, and save billions in healthcare costs. Studies show that when out-of-pocket costs drop, people take their meds-leading to better health and fewer preventable deaths.

Published ON: 14 Feb

categories

archives

tags

generic drugs drug interactions dietary supplement medication safety online pharmacy health benefits bioequivalence side effects dietary supplements physical therapy FDA MedWatch drug pricing connection erectile dysfunction gut health management treatment role weight loss next big thing